RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Georgetown Lombardi Comprehensive Cancer Center, Washington D.C., District of Columbia Medstar Washington Hospital Center, Washington D.C., District of Columbia John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey Last updated December 2025